4th Quarter - Report

FIERCE, ISAKOWITZ & BLALOCK for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Generic Biologics H.R.1038/S.623: Access to Life-Saving Medicine Act S.1695: Biologics Price Competition and Innovation Act of 2007 H.R.5629: Pathway for Biosimiliars Act

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 623 (110th), H.R. 5629 (110th), H.R. 1038 (110th), S. 1695 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.